ZIVO
Zivo Bioscience, Inc.
Latest Form 4:Purchase$200KbySTROME MARK E (10% Owner) · filed Apr 24, 2026
Zivo Bioscience, Inc. (ZIVO) has 10 SEC Form 4 filings (10 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Apr 24, 2026.
The most active filer is Director, 10% Owner YALDOO LAITH L with 4 filings. Insiders have net bought $690K over the trailing 6 months.
- Industry:Biotechnology
- CEO:John Bernard Payne
- Employees:7
- HQ:Troy, MI, US
- IPO:2003-12-15
Insider Buying
$940K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
| 10% Owner | Purchase | 100,000 | $200K | Apr 24 | SEC ↗ | |
| Director, 10% Owner | Purchase | 1,543 | $15K | Mar 3 | SEC ↗ | |
| 10% Owner | Purchase | 20,000 | $195K | Feb 17 | SEC ↗ | |
| Director, 10% Owner | Purchase | 2,434 | $25K | Feb 12 | SEC ↗ | |
Cornell Alison AFirst filing | Director | Purchase | 11,709 | $100K | Jan 28 | SEC ↗ |
PAYNE JOHN BERNARDFirst filing | President and CEO | Purchase | 11,709 | $100K | Jan 28 | SEC ↗ |
Maggiore Christopher D.First filing | Director, 10% Owner | Purchase | 1,766 | $15K | Jan 27 | SEC ↗ |
| Director, 10% Owner | Purchase | 1,766 | $15K | Jan 27 | SEC ↗ | |
YALDOO LAITH LFirst filing | Director, 10% Owner | Purchase | 2,777 | $25K | Dec 2 | SEC ↗ |
STROME MARK EFirst filing | 10% Owner | Purchase | 20,259 | $250K | Oct 20 | SEC ↗ |
Related companies
Zivo Bioscience, Inc. is in the Healthcare sector.